AML (ACUTE MYELOGENOUS LEUKEMIA)
Clinical trials for AML (ACUTE MYELOGENOUS LEUKEMIA) explained in plain language.
Never miss a new study
Get alerted when new AML (ACUTE MYELOGENOUS LEUKEMIA) trials appear
Sign up with your email to follow new studies for AML (ACUTE MYELOGENOUS LEUKEMIA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Broccoli compound tested to speed up recovery in blood cancer patients
Disease control Recruiting nowThis study is testing whether a dietary supplement called sulforaphane, found in foods like broccoli, is safe and can help patients recover their blood cell counts faster after a cord blood transplant. It will involve 36 adults with serious blood cancers like leukemia who receive…
Matched conditions: AML (ACUTE MYELOGENOUS LEUKEMIA)
Phase: NA • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Mar 25, 2026 14:09 UTC
-
New hope for blood cancer patients: trial tests better protection after transplants
Disease control Recruiting nowThis study aims to find the best drug combination to prevent graft-versus-host disease (GVHD), a serious complication where donor immune cells attack the patient's body after a stem cell transplant. Researchers are comparing two new drug combinations against the current standard …
Matched conditions: AML (ACUTE MYELOGENOUS LEUKEMIA)
Phase: PHASE2 • Sponsor: Center for International Blood and Marrow Transplant Research • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
New hope for kids: gentler chemo tested for leukemia in children with down syndrome
Disease control Recruiting nowThis study aims to find the best way to treat a specific type of leukemia (AML) in children who also have Down syndrome. It will test a standardized, four-part chemotherapy plan across multiple hospitals in Russia. The goal is to help these children live longer, healthier lives b…
Matched conditions: AML (ACUTE MYELOGENOUS LEUKEMIA)
Phase: PHASE3 • Sponsor: Federal Research Institute of Pediatric Hematology, Oncology and Immunology • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
New hope for patients Who've run out of options: early trial tests novel blood cancer drug
Disease control Recruiting nowThis is a first-in-human study to test a new drug called CG009301 in adults with blood cancers that have returned or stopped responding to standard treatments. The main goals are to find a safe dose and see how the body processes the drug. About 45 participants will receive the t…
Matched conditions: AML (ACUTE MYELOGENOUS LEUKEMIA)
Phase: PHASE1 • Sponsor: Cullgen (Shanghai),Inc • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC
-
Researchers hunt for clues to make leukemia treatment safer
Knowledge-focused Recruiting nowThis study aims to understand why some leukemia patients in remission experience severe side effects from a common maintenance drug combination. Researchers will measure drug levels in the blood of 14 patients to see if higher levels are linked to more severe low blood counts. Th…
Matched conditions: AML (ACUTE MYELOGENOUS LEUKEMIA)
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:08 UTC